Kura Oncology to Participate in Bank of America Securities Healthcare Conference

Kura Oncology (Nasdaq: KURA) will participate in the Bank of America Securities 2026 Healthcare Conference on May 13, 2026.

Rhea-AI Summary

Kura Oncology (Nasdaq: KURA) will participate in the Bank of America Securities 2026 Healthcare Conference on May 13, 2026. Management is scheduled for a fireside chat at 6:00 p.m. ET / 3:00 p.m. PT. A live webcast and archived replay will be available on the company Investors website.

Argus May 6 session

+2.91% close to close Open Argus

Details

News Market Reaction – KURA

On May 6, the day this news came out, KURA closed 2.91% above the previous close.

Data tracked by StockTitan Argus for the May 6 session.

Market Context

This announcement highlights Kura’s plan to engage investors through a fireside chat at a major heal...

Analysis

This announcement highlights Kura’s plan to engage investors through a fireside chat at a major healthcare conference on May 13, 2026. It fits within a pattern of regular communications alongside recent clinical, financial, and governance disclosures. Investors following the name may focus on what incremental detail, if any, management provides on commercialization progress, pipeline development, and capital allocation beyond what has already appeared in prior filings and updates.

Key Figures

Conference date: May 13, 2026 Fireside chat time ET: 6:00 p.m. ET Fireside chat time PT: 3:00 p.m. PT

Conference date

May 13, 2026

Bank of America Securities 2026 Healthcare Conference participation

Fireside chat time ET

6:00 p.m. ET

Scheduled management fireside chat

Fireside chat time PT

3:00 p.m. PT

Scheduled management fireside chat

Historical Context

5 past events · Latest: May 04

5 events

1. May 04

   Inducement option grants

   24h Move

   +5.5%

   New employee stock options totaling 133,750 shares at $8.77 exercise price.

2. Apr 17

   Clinical data update

   24h Move

   +8.3%

   Darlifarnib plus cabozantinib showed robust activity in ccRCC patients.

3. Apr 09

   Conference presentation

   24h Move

   +0.7%

   Planned IKCS Europe 2026 presentation of updated FIT-001 RCC data.

4. Mar 06

   Inducement option grants

   24h Move

   +5.3%

   Inducement options for four new employees totaling 44,700 shares at $8.68.

5. Mar 05

   Earnings and update

   24h Move

   -0.5%

   Q4 and 2025 results with KOMZIFTI approval, $2.1M revenue and strong cash.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in the Bank of America Securities 2026 Healthcare Conference. Kura management is scheduled to participate in a fireside chat at 6:00 p.m. ET / 3:00 p.m. PT on May 13, 2026.

The live webcast and archived replay of the event may be accessed on the Investors section of the Company’s website at www.kuraoncology.com.

About Kura Oncology
Kura Oncology is a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Kura’s pipeline of small molecule drug candidates is designed to target cancer signaling pathways and address high-need hematologic malignancies and solid tumors. Kura developed and is commercializing KOMZIFTI™ (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit the Kura website at https://kuraoncology.com/ and follow us on X and LinkedIn.

Kura Contact

Investors and Media:
Greg Mann
858-987-4046
gmann@kuraoncology.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Kura Oncology (KURA) present at the Bank of America Securities 2026 Healthcare Conference?

Kura Oncology will present on May 13, 2026 at 6:00 p.m. ET / 3:00 p.m. PT. According to Kura Oncology, management is scheduled for a fireside chat on that date during the conference and will appear live via webcast.

How can investors watch the KURA fireside chat on May 13, 2026?

Investors can watch the live webcast via the company Investors website. According to Kura Oncology, the live webcast will stream on the Investors section at www.kuraoncology.com, with an archived replay posted after the event for later viewing.

Will there be an archived replay of Kura Oncology's (KURA) conference presentation?

Yes, an archived replay will be available after the live event on the company website. According to Kura Oncology, the replay will be accessible in the Investors section at www.kuraoncology.com for investors who cannot attend the live webcast.

What format will Kura Oncology (KURA) use to present at the Bank of America Healthcare Conference?

Kura Oncology management will participate in a fireside chat format during the conference session. According to Kura Oncology, the company’s management team is scheduled for a fireside chat on May 13, 2026, followed by a live webcast and subsequent replay.

What is Kura Oncology's ticker and where can I find the conference webcast and details?

Kura Oncology trades as Nasdaq: KURA; webcast details are on the company Investors webpage. According to Kura Oncology, the live webcast and archived replay for the May 13, 2026 presentation are available at www.kuraoncology.com in the Investors section.